Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Artificial Intelligence-Assisted Processing of Anterior Segment OCT Images in the Diagnosis of Vitreoretinal Lymphoma.
Gozzi F, Bertolini M, Gentile P, Verzellesi L, Trojani V, De Simone L, Bolletta E, Mastrofilippo V, Farnetti E, Nicoli D, Croci S, Belloni L, Zerbini A, Adani C, De Maria M, Kosmarikou A, Vecchi M, Invernizzi A, Ilariucci F, Zanelli M, Iori M, Cimino L. Gozzi F, et al. Among authors: adani c. Diagnostics (Basel). 2023 Jul 23;13(14):2451. doi: 10.3390/diagnostics13142451. Diagnostics (Basel). 2023. PMID: 37510195 Free PMC article.
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet's Uveitis: Customizing Therapy according to the Clinical Features.
De Simone L, Invernizzi A, Aldigeri R, Mastrofilippo V, Marvisi C, Gozzi F, Bolletta E, Adani C, Pipitone N, Muratore F, Fontana L, Salvarani C, Cimino L. De Simone L, et al. Among authors: adani c. Ocul Immunol Inflamm. 2022 Feb 17;30(2):506-514. doi: 10.1080/09273948.2020.1815797. Epub 2020 Oct 6. Ocul Immunol Inflamm. 2022. PMID: 33021421
Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment.
Bolletta E, Gozzi F, Mastrofilippo V, Pipitone N, De Simone L, Croci S, Invernizzi A, Adani C, Iannetta D, Coassin M, Fontana L, Salvarani C, Cimino L. Bolletta E, et al. Among authors: adani c. Ocul Immunol Inflamm. 2022 Aug;30(6):1303-1308. doi: 10.1080/09273948.2021.1880604. Epub 2021 Apr 1. Ocul Immunol Inflamm. 2022. PMID: 33793383
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
Bolletta E, Coassin M, Iannetta D, Mastrofilippo V, Aldigeri R, Invernizzi A, de Simone L, Gozzi F, De Fanti A, Cappella M, Adani C, Neri A, Moramarco A, De Maria M, Salvarani C, Fontana L, Cimino L. Bolletta E, et al. Among authors: adani c. J Clin Med. 2021 May 31;10(11):2437. doi: 10.3390/jcm10112437. J Clin Med. 2021. PMID: 34072679 Free PMC article.
Uveitis and Other Ocular Complications Following COVID-19 Vaccination.
Bolletta E, Iannetta D, Mastrofilippo V, De Simone L, Gozzi F, Croci S, Bonacini M, Belloni L, Zerbini A, Adani C, Fontana L, Salvarani C, Cimino L. Bolletta E, et al. Among authors: adani c. J Clin Med. 2021 Dec 19;10(24):5960. doi: 10.3390/jcm10245960. J Clin Med. 2021. PMID: 34945256 Free PMC article.
Clinical Features and Prevalence of Spondyloarthritis in a Cohort of Italian Patients Presenting with Acute Nongranulomatous Anterior Uveitis.
Bolletta E, Macchioni P, Citriniti G, Mastrofilippo V, Aldigeri R, De Simone L, Gozzi F, Adani C, Sangiovanni A, Posarelli C, Figus M, Muratore F, Pipitone N, Salvarani C, Cimino L. Bolletta E, et al. Among authors: adani c. J Immunol Res. 2022 Jan 18;2022:6632081. doi: 10.1155/2022/6632081. eCollection 2022. J Immunol Res. 2022. PMID: 35087912 Free PMC article.
Could different aqueous humor and plasma cytokine profiles help differentiate between ocular sarcoidosis and ocular tuberculosis?
De Simone L, Bonacini M, Aldigeri R, Alessandrello F, Mastrofilippo V, Gozzi F, Bolletta E, Adani C, Zerbini A, Cavallini GM, Fontana L, Salvarani C, Croci S, Cimino L. De Simone L, et al. Among authors: adani c. Inflamm Res. 2022 Aug;71(7-8):949-961. doi: 10.1007/s00011-022-01601-2. Epub 2022 Jun 28. Inflamm Res. 2022. PMID: 35763079
22 results